Loading...
XSWX
TECN
Market cap2.75bUSD
Jul 09, Last price  
175.00CHF
1D
4.29%
1Q
29.73%
Jan 2017
10.13%
IPO
6.71%
Name

Tecan Group AG

Chart & Performance

D1W1MN
XSWX:TECN chart
P/E
P/S
2.51
EPS
Div Yield, %
1.71%
Shrs. gr., 5y
1.03%
Rev. gr., 5y
3.84%
Revenues
882m
-5.54%
405,929,000414,400,000396,042,000391,910,000370,548,000376,970,000391,108,000388,292,000399,518,000440,295,000506,227,000548,559,000593,795,000636,819,000730,879,000946,623,0001,144,261,0001,074,386,000934,278,000882,480,000
Net income
-111m
L
40,639,00052,379,00025,623,00049,340,00016,204,00047,559,00042,155,00045,671,00040,216,00057,147,00054,542,00066,547,00070,696,00073,169,000103,685,000121,659,000121,126,000132,075,00067,664,000-110,653,000
CFO
138m
-7.11%
66,087,00058,623,00058,929,00066,150,00062,520,00045,116,0002,405,00027,909,00048,191,00099,128,000118,801,00099,428,00092,702,00097,971,000207,416,000165,838,000127,474,000160,572,000148,541,000137,976,000
Dividend
Apr 14, 20253 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tecan Group AG delivers advanced laboratory instruments and complete solutions to a diverse client base, including pharmaceutical and biotechnology companies, academic research institutions, and both forensic and diagnostic laboratories. The company operates through two primary segments: Life Sciences Business and Partnering Business. Its comprehensive product range features liquid handling and automation systems, microplate readers and washers, various consumables, next-generation sequencing (NGS) reagents, immunoassays, microbodies, and specialized software. Key offerings include Tecan Laberwax, an innovative automation solution, and Resolvex, an intelligent sample preparation system utilized in fields such as genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. Furthermore, Tecan develops and manufactures essential components like precision pumps, valves, robotic arms, and developer software, supplying these to other laboratory instrument manufacturers for use in life science research, diagnostics, and other industries. Its automation portfolio also includes platforms like Synergence and renowned instruments such as Freedom EVO and Fluent. With a global presence, Tecan Group AG conducts operations across Switzerland, Europe, North America, Asia, and other international markets. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
IPO date
May 04, 2001
Employees
3,000
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT